Cargando…
(11)C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to (18)F-FDG PET/CT and Prognostic Value
Multiple myeloma (MM) is the second most common haematological malignancy and remains incurable despite therapeutic advances. (18)F-FDG (FDG) PET/CT is a relevant tool MM for staging and it is the reference imaging technique for treatment evaluation. However, it has limitations, and investigation of...
Autores principales: | Morales-Lozano, Maria I., Rodriguez-Otero, Paula, Sancho, Lidia, Nuñez-Cordoba, Jorge M., Prieto, Elena, Marcos-Jubilar, Maria, Rosales, Juan J., Alfonso, Ana, Guillen, Edgar F., San-Miguel, Jesus, Garcia-Velloso, Maria J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456410/ https://www.ncbi.nlm.nih.gov/pubmed/36077292 http://dx.doi.org/10.3390/ijms23179895 |
Ejemplares similares
-
(18)F-FDG and (11)C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers
por: Morales-Lozano, Maria I, et al.
Publicado: (2020) -
PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021) -
(11)C-Methionine PET/CT and (18)F-FDG PET/CT in the Evaluation of Adult Alveolar Rhabdomyosarcoma
por: Hiroshima, Yuka, et al.
Publicado: (2023) -
FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013) -
Effective dose estimation for oncological and neurological PET/CT procedures
por: Martí-Climent, Josep M., et al.
Publicado: (2017)